Compounds / GHK-Cu

GHK-Cu

Copper peptide

GHK-Cu has 3 registered human trials on record. It is marketed for 3 different uses.

In short

  • 3 registered human trials exist for GHK-Cu.
  • No registered trial lists hair growth as a studied condition.
  • GHK-Cu is not FDA-approved for any use.
  • What has actually been studied: ghk and ghk-cu blood levels, acute standardized cutaneous wounds (punch-biopsy wounds).
  • 2 studies are open to new participants, so this may change.
  • Last checked against ClinicalTrials.gov on 2026-07-27.
3
Registered human trials
2
Recruiting or running
No
FDA approved
Pre
P1
P2
P3
Furthest stage reached

What it's sold for

  • Skin repair & anti-aging
  • Hair growth
  • Wound healing

What has actually been tested

  • Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)
  • Cutis Laxa Facialis
  • GHK and GHK-Cu Blood Levels
  • Xeroderma

Is it studied for what it's sold for?

Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.

Studied Skin repair & anti-aging
Not listed Hair growth
Studied Wound healing

Every trial on record

Every registered human study we can find for GHK-Cu. Click any ID to read the original record — we would rather you checked us than trusted us.

Trial IDTitleConditionPhaseStatusEnrolled
NCT07706361 Two-Part Study of the Effects of the X39 Patch on Circulating GHK and GHK-Cu Levels in Healthy Adults GHK and GHK-Cu Blood Levels Not phased Not yet recruiting 100
NCT07437586 Topical GHK-Cu Gel for Acute Skin Wound Healing Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds) Phase 2 Recruiting now 60
NCT05932732 Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types. Cutis Laxa Facialis, Xeroderma Phase 4 Completed 27
Read this
A trial count is not a verdict
These numbers describe how much has been formally studied in humans, not whether something works or is safe for you. A compound can be tested for one condition and sold for another — which is usually the story. This page is automated aggregation from public registries; no physician has reviewed it. Take anything here to a clinician.

Common questions about GHK-Cu

How many human trials does GHK-Cu have?

3. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.

Is GHK-Cu FDA approved?

No. GHK-Cu is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.

What is GHK-Cu actually being tested for?

Registered studies cover: ghk and ghk-cu blood levels, acute standardized cutaneous wounds (punch-biopsy wounds), cutis laxa facialis. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.

Where does this data come from?

ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.

Get told when this changes

One email a week: what moved in the research, and which claims the record doesn't support. Free, and you can leave in one click.